Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials

(2018) James Bussel et al.   AMERICAN JOURNAL OF HEMATOLOGY

Splenectomy for immune thrombocytopenia: down but not out

(2018) Shruti Chaturvedi et al.   BLOOD

Systematic Literature Review of Treatments Used for Adult Immune Thrombocytopenia (ITP) in the Second-line Setting

(2018) Lauren C. Bylsma et al.   AMERICAN JOURNAL OF HEMATOLOGY

Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years

(2016) Francesca Palandri et al.   AMERICAN JOURNAL OF HEMATOLOGY

Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines

(2016) María Luisa Lozano et al.   ANNALS OF HEMATOLOGY

Controversies in the treatment of immune thrombocytopenia

(2016) Adam Cuker et al.   CURRENT OPINION IN HEMATOLOGY

Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US

(2016) Karynsa Cetin et al.   Clinical Epidemiology

Current Management of Primary Immune Thrombocytopenia

(2015) Drew Provan et al.   ADVANCES IN THERAPY

Outpatient Management of Patients with Immune Thrombocytopenia (ITP) by Hematologists 1995-2014

(2015) Rudolf Weide et al.   Oncology Research and Treatment

Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis

(2015) Shaan Chugh et al.   Lancet Haematology

Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?

(2014) Julie Navez et al.   PLATELETS

Management of Primary Immune Thrombocytopenia, 2012: A Survey of Oklahoma Hematologists-Oncologists

(2013) Kaelyn H. Lu et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

(2013) S. Gudbrandsdottir et al.   BLOOD

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment

(2012) W. Ghanima et al.   BLOOD

Contemporary management of primary immune thrombocytopenia in adults

(2012) S. LAKSHMANAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes

(2010) Deirdra R. Terrell et al.   AMERICAN JOURNAL OF HEMATOLOGY

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Treatment practices in adults with chronic immune thrombocytopenia – a European perspective

(2009) Francesco Rodeghiero et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Intravenous Immunoglobulin and Anti-RhD Therapy in the Management of Immune Thrombocytopenia

(2009) Nichola Cooper   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

(2009) James B Bussel et al.   LANCET

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

(2008) J. B. Bussel et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET